Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?

Shares of Sarepta Therapeutics (SRPT) have soared 43% year to date, significantly outperforming the industry’s 6.9% decline. The stock has also underperformed the sector and the S&P 500 during the same period, as shown in the chart below. SRPT’s shares are trading above the 50 and 200-day moving averages.SRPT Stock Outperforms Industry, Sector & S&P 500 Image Source: Zacks Investment ResearchThe surge in the stock price can be attributed to the encouraging sales performance of Duchenne muscular dystrophy (D ...